Incyte insider sales
WebApr 13, 2024 · Insider Transactions at Incyte. ... The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, EVP Vijay K. Iyengar sold 7,000 shares of Incyte stock in a transaction that occurred on Thursday, January 26th. The stock was sold at an average price of $85.00, for a ... WebApr 9, 2024 · Insider Buying and Selling at Incyte In other news, EVP Maria E. Pasquale sold 60,024 shares of Incyte stock in a transaction dated Monday, January 30th. The stock was sold at an average...
Incyte insider sales
Did you know?
WebApr 15, 2024 · In other Incyte news, EVP Maria E. Pasquale sold 60,024 shares of the stock in a transaction on Monday, January 30th. The shares were sold at an average price of $84.74, for a total value of $5,086,433.76. Following the completion of the sale, the executive vice president now directly owns 68,524 shares of the company's stock, valued at … WebFeb 8, 2024 · Incyte Reports 2024 Fourth Quarter and Year-end Financial Results and Provides 2024 Financial Guidance and Updates on Key Clinical Programs ... 2024 reflects an increase in net product sales as a ...
WebJul 1, 2024 · Sales 2024: 3 766 M--Net income 2024: 653 M--Net cash 2024: 3 454 M--P/E ratio 2024: 24,8x: Yield 2024- WebSep 27, 2024 · (RTTNews) - Syndax Pharmaceuticals, Inc. (SNDX) and Incyte (INCY) have entered into a worldwide collaboration and license agreement to develop and commercialize axatilimab, Syndax's anti-CSF-1R...
WebFind the latest Insider Activity data for Incyte Corp. Common Stock (INCY) at Nasdaq.com. WebMar 24, 2024 · Jakafi sales came in at $2.4 billion in 2024, contributing 71% to total revenues. Incyte has a collaboration agreement with Swiss pharma giant Novartis (. NVS …
WebApr 13, 2024 · Insider Buying and Selling. In related news, EVP Maria E. Pasquale sold 60,024 shares of Incyte stock in a transaction on Monday, January 30th. The stock was sold at an average price of $84.74 ...
WebNov 28, 2014 · We believe that the stock price of Incyte, a global biopharmaceutical company, is undervalued at current levels of $75. INCY stock is down 21% over the last … truro waterfront cottagesWebIncyte Corp. 1801 Augustine Cut-Off Wilmington, Delaware 19803 Phone 1 302 498-6700 Industry Biotechnology Sector Health Care/Life Sciences Fiscal Year-end 12/2024 Revenue $2.99B Net Income... philippine team building gamesWebApr 10, 2024 · The Incyte Thesis: Setbacks in LIMBER and the recent competitor advancement underline “the need for better execution of life-cycle strategies to enable optimal revenue sustainment beyond the ... philippine team finderWebJul 1, 2024 · March 25, 2024. Herve Hoppenot: Chairman, President & Chief Executive Officer: Christiana Stamoulis truro webcamWebWe would like to show you a description here but the site won’t allow us. philippine technology transfer act of 2009WebGet Incyte Corp (INCY:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. truro wedding mintWebApr 15, 2024 · 3.00. Incyte currently has a consensus price target of $85.43, suggesting a potential upside of 14.67%. MaxCyte has a consensus price target of $10.50, suggesting a potential upside of 96.26% ... truro wedding dress shops